Welcome to our dedicated page for Oddity Tech Ltd. SEC filings (Ticker: ODD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oddity Tech Ltd pioneers the fusion of AI and beauty, but the company’s disruptive model also means its SEC documents can be dense with data on algorithmic IP, biotechnology R&D and direct-to-consumer margins. If you have ever searched, “Oddity Tech SEC filings explained simply,� this page is built for you.
Here you’ll find every disclosure—annual report 10-K, quarterly earnings report 10-Q, current report 8-K, proxy statement on executive compensation and each Oddity Tech insider trading Form 4 transaction—updated the second they hit EDGAR. Stock Titan’s AI turns those hundreds of pages into concise, plain-English takeaways: brand-level revenue trends, cash use for biotech initiatives in Boston, and how marketing algorithms affect inventory. Want real-time alerts? Our platform flags Oddity Tech Form 4 insider transactions so you can monitor executive stock activity without refreshing filings.
Use cases investors tell us about include:
- Comparing gross margin shifts across IL MAKIAGE and SpoiledChild via the latest Oddity Tech quarterly earnings report 10-Q filing.
- Tracking AI-related patent purchases disclosed in an Oddity Tech 8-K material events explained section.
- Reviewing the Oddity Tech proxy statement executive compensation to understand incentives that drive growth.
- Spotting buying or selling patterns through Oddity Tech executive stock transactions Form 4.
StoneX Group Inc. (SNEX) � Form 4 insider activity
Director John M. Fowler reported the award of 139 restricted common shares on 31 Jul 2025 (transaction code “A�) under the company’s Restricted Stock Program. The grant carries no cash price and will vest in three equal annual tranches. After the transaction Fowler now directly owns 116,874 SNEX shares and indirectly holds 3,000 shares through his spouse.
No sales, options, or other derivative transactions were disclosed. While the filing reflects continued insider alignment, the incremental shares represent less than 0.5 % of his current stake and are unlikely to be material to StoneX’s equity structure.